Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic Dermatitis

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 7, 2019

Primary Completion Date

February 3, 2022

Study Completion Date

December 31, 2022

Conditions
Atopic Dermatitis
Interventions
OTHER

Clinical examination

This is a classic dermatological clinical examination during a classic consultation

PROCEDURE

Biopsies

"2 skin biopsies on a lesion area selected according to the inclusion criteria (2 punchs of 4 mm) for each experimental group.~The first half of whole cutaneous biopsies (n = 25) will be studied using biphotonic microscopy. This will be performed on whole biopsies in 3-D according to the protocol developed in the laboratory.~The second half of whole skin biopsies (n = 25) will be studied using the technique of single-cell RNA seq.~The skin controls skin-free subjects will be obtained from skin reduction surgery (abdominoplasty) to subjects who have agreed to the use of their skin sample."

OTHER

Blood test

A blood test on a tube (2 tubes of 10 mL).An assay of specific IgE and the serum level of IL-4, IL-13 and IL-5 will be carried out by ELISA (Enzyme Linked ImmunoSorbent Assay) from the blood samples.The blood samples will be obtained through the French blood establishment from different donors who have given their consent.

Trial Locations (1)

31059

CHU de TOULOUSE, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT04193670 - Sensory Nociceptive Nerve Fibers, Key Regulator of Immune Response Type 2 in Atopic Dermatitis | Biotech Hunter | Biotech Hunter